Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #92

    God morgen. 🙂

    1 Reply Last reply
    0
    • T Offline
      T Offline
      transalp
      wrote on sidst redigeret af
      #93

      Go morgen.. 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #94

        Vincent Rajkumar
        @VincentRK
        ·
        7 t
        Today @US_FDA
        @FDAOncology
        approved isatuximab (Sarclisa) for relapsed refractory myeloma.

        Im happy that @SanofiUS
        has priced it significantly lower than daratumumab. I hope there is a price war, & prices drop more. Based on cost, I’ll prefer Isa-PomDex to Dara-PomDex. @mtmdphd

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #95

          Vincent Rajkumar
          @VincentRK
          ·
          7 t
          I was an author on the isatuximab pivotal trial. Im working with both @sanofi
          and @JanssenUS
          on other trials.

          Look forward to thoughts on how we support the appropriate choice of drug taking cost into account from @Rfonsi1
          @akeithstewart
          @peterbachmd
          & others who are interested

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #96

            #ACTRIMS2020 – Results of Ofatumumab Self-injection Pen Equivalent to Infusion, APLIOS Trial Shows https://multiplesclerosisnewstoday.com/news-posts/2020/02/28/actrims2020-poster-session-lb300-onset-of-b-cell-depletion-with-subcutaneous-administration-of-ofatumumab-in-relapsing-multiple-sclerosis-results-from-the-aplios-bioequivalence-study

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #97

              CureVac still in the Coronavirus Vaccine race https://www.globenewswire.com/news-release/2020/03/02/1993888/0/en/CureVac-CEO-Daniel-Menichella-Discusses-Coronavirus-Vaccine-Development-with-U-S-President-Donald-Trump-and-Members-of-Coronavirus-Task-Force.html

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #98

                Karyopharm. https://www.statnews.com/2020/03/02/karyopharm-to-seek-expanded-use-of-multiple-myeloma-drug-following-positive-clinical-trial/

                1 Reply Last reply
                0
                • V Offline
                  V Offline
                  Vitus
                  wrote on sidst redigeret af
                  #99

                  Tegner til en forrygende åbning 🙂

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #100

                    Godt spg, Jazzz 23:14, Er det EQUULEUS vi skal sammenligne med ?

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #101

                      Det største problem med Sanofi er, at pt sælger Genmab mest med Daratumumab i kombination med POM-DEX, så det er lidt samme patientgrundlag. Tilsyneladende er denne kombi ogås meget brugt i anden linie, så spørgsmålet er om Sanofi også kan vinde indpas der med en lavere prissætning. Lad os håbe at sc dosering er en game changer som Jan siger - omvendt kan Sanofi indpas gøre det svært for JNJ at hæve prisen pt.

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #102

                        Karyopharm henter penge igen

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #103

                          Just a moment...

                          favicon

                          (www.firstwordpharma.com)

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #104

                            i would anyway be a little bit carefull believing Rajkumar's price information ; he has made mistakes with that before. JNJ felt comfortable enough to raise Dara pricing 4.9% in Jan

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #105

                              Angående Sanofi og isatuximab, så kommer det jo ikke som nogen overraskelse, så Genmab har jo haft dette med i deres guidance.

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #106

                                I agreed E L.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #107

                                  Link Preview Image
                                  Siden kunne ikke findes | Euroinvestor

                                  favicon

                                  Euroinvestor (www.euroinvestor.dk)

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #108

                                    The price: Sarclisa med en listepris på 650 dollar per dosis på 100 milligram og 3250 dollar per dosis med 500 milligram.

                                    1 Reply Last reply
                                    0
                                    • F Offline
                                      F Offline
                                      Farmaceuten
                                      wrote on sidst redigeret af
                                      #109

                                      Har Karyopharm - spændende hvor markedet reagrer ovenpå den stigning i går. Og så LIGE efter melder ud at de skal hente penge... Smart timing 😉

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #110

                                        Access Denied

                                        favicon

                                        (www.drugs.com)

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #111

                                          The U.S. list price (wholesale acquisition cost, or WAC) for Sarclisa is $650 per 100 mg vial and $3,250 per 500 mg vial. For a typical patient in the U.S., between 70-80 kg (154-176 lbs), this correlates to a cost of $5,200 per infusion. Actual costs to patients are generally anticipated to be lower as the list price does not reflect insurance coverage, copay support, or financial assistance from patient support programs.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger